Hagelauer, Nadine <br/><br/>
Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation.  [electronic resource] 

 -  Clinical oral investigations  Jun 2015 
 - 1079-91 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1436-3771 
<br/><br/><label>Standard No.: </label>10.1007/s00784-014-1320-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bisphosphonate-Associated Osteonecrosis of the Jaw--prevention & control<br/>Bone Density Conservation Agents--toxicity<br/>Cell Movement--drug effects<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Cyclohexenes--pharmacology<br/>Diphosphonates--toxicity<br/>Diterpenes--pharmacology<br/>Endothelial Cells--drug effects<br/>Eugenol--pharmacology<br/>Farnesol--pharmacology<br/>Fibroblasts--drug effects<br/>Humans<br/>Imidazoles--toxicity<br/>Limonene<br/>Menthol--pharmacology<br/>Osteogenesis--drug effects<br/>Protein Prenylation<br/>Recurrence<br/>Squalene--pharmacology<br/>Terpenes--pharmacology<br/>Umbilical Veins--cytology<br/>Zoledronic Acid